P1.07.49 Limited Impact of Adjuvant Chemotherapy in Alk-Positive Stage II-III Adenocarcinoma: A Multicenter CReGYT-03 ALK StudyAkira Hamada, Y. Tsutani, Asato Hashinokuchi et al.|Journal of Thoracic Oncology|2025Cited by 0